Public COA audit

Semaglutide

Audited September 5, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
72
Confidence
88%
Panels
1/7

Scored moderately because the document is mostly consistent but carries soft concerns, limited panel coverage (1/7), 3 soft concerns, and notable note: "Sterility screening present". To improve: include identity, purity, and endotoxin at minimum and prefer labs with a public verification portal.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
SM202607
Sample date
2026-06-10
Issue date
2026-06-10

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

1 of 7 present · 1 passed · 0 failed · 0 reported · 6 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Not on this certificate file · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Purity

    Not on this certificate file · core

    Reported purity percentage for the analyte.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Not on this certificate file · core

    LAL or chromogenic endotoxin assay.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Sterility

    Tested · passed

    Sterility testing where applicable.

    No Growth (Bacteria), Not Detected (Fungi/Yeast)

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • Sterility screening present

    Document shows rapid sterility screening with bacteria (aerobic/anaerobic) and fungi/yeast testing, both passing with no growth detected.

  • Limited scope - sterility only

    This is a sterility-specific report. No purity, identity, heavy metals, endotoxin, microbial count, or residual solvent testing is included in this document. This may be part of a multi-report suite for the lot.

  • Rapid screening method disclaimer

    Document explicitly states this is a rapid screening method (2-day incubation) suitable for quality control but notes that full USP <71> sterility testing may be required for regulatory compliance. This is a preliminary assessment, not a full compendial sterility test.

  • Lot number present

    Lot number SM202607 clearly stated.

  • Same-day turnaround

    Sample received and certified on the same date (2026-06-10), consistent with a rapid screening method.

  • Lab verification not possible

    Kovera Labs is named as the testing facility. No website URL or independent verification mechanism is provided beyond the access code and QR code shown on the document.

  • Professional presentation

    Document has clean, professional formatting with clear sections, a report number (KVR-2026-D8F3B3), access code (D8F3B3), and QR code for potential verification.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.